Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis

Affiliations

• ¹ Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
• ² Department of General Surgery, Xiangya Hospital Central South University, Changsha, China.
• ³ Department of Breast Internal Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
• ⁴ Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, China.
• ⁵ Department of Breast and Thyroid Surgery, Hunan Provincial People's Hospital, Changsha, China.
• ⁶ Department of Breast and Thyroid Surgery, Central South University Third Xiangya Hospital, Changsha, China.
• ⁷ Department of Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
• ⁸ Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.
• ⁹ Department of Breast Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
• ¹⁰ Department of Traditional Chinese Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
• ¹¹ Department of Internal Medicine - Oncology, Xiangya Hospital Central South University, Changsha, China.
• ¹² Department of Breast Surgery, The First Hospital Hunan University of Chinese Medicine, Changsha, China.
• ¹³ Department of Breast and Thyroid Surgery, The Affiliated ZhuZhou Hospital of Xiangya School of Medicine Central South University, Zhuzhou, China.
• ¹⁴ Department of Oncology, The Affiliated ZhuZhou Hospital of Xiangya School of Medicine Central South University, Zhuzhou, China.
• ¹⁵ Department of Breast Surgery, The Third People's Hospital of Yongzhou, Yongzhou, China.
• ¹⁶ Department of Oncology, The First People's Hospital of Yueyang, Yueyang, China.
• ¹⁷ Department of Breast and Thyroid Surgery, The First People's Hospital of Xiangtan City, Xiangtan, China.
• ¹⁸ Department of Oncology, The Third People's Hospital of Changde, Changde, China.
• ¹⁹ Department of Oncology, Xiangtan Central Hospital, Xiangtan, China.
• ²⁰ Department of General Surgery, Xiangtan Central Hospital, Xiangtan, China.
• ²¹ Department of Oncology, Central Hospital of Shaoyang, Shaoyang, China.
• ²² Department of Breast and Thyroid Surgery, Central Hospital of Shaoyang, Shaoyang, China.
• ²³ Department of Breast Surgery, Shaoyang Hospital of Traditional Chinese Medicine, Shaoyang, China.
• ²⁴ Department of Oncology, The First People's Hospital of Changde, Changde, China.
• ²⁵ Department of Oncology, The Third Hospital of Hunan University of Chinese Medicine, Zhuzhou, China.
• ²⁶ Department of Oncology, The Central Hospital of Yiyang, Yiyang, China.
• ²⁷ Department of Internal Medicine - Oncology, The First People's Hospital of Chenzhou, Chenzhou, China.
• ²⁸ Department of Breast and Thyroid Surgery, The People's Hospital of Xiangtan County, Xiangtan, China.